Evolus (EOLS) PT Lowered to $25 at Mizuho Securities on 3Q Report; 'Higher OpEx Forecast' for 4Q

Mizuho Securities analyst Irina Koffler lowered the price target on Evolus (NASDAQ: EOLS) to $25.00 (from $27.00) while maintaining a Buy rating, following the company's third quarter earnings report.

Analyst Koffler notes a reduced outlook on the shares, as EOLS reported third quarter earnings per shares above consensus, which doesn't appear to be meaningful, while introducing higher projected operating expenses for the fourth quarter, ahead of a potential Spring 2019 launch of DWP-450

You May Also Be Interested In

• BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $85 at Scotiabank
• Rogers Communications (RCI/B:CN) (RCI) PT Lowered to Cdn$71 at Canaccord Genuity
• HSBC Upgrades UPS (UPS) to Buy, 'Back to earnings growth'